Talissa A. Altes

Talissa A. Altes

Auto-generated profile, based on publicly available information

Talissa A. Altes

Department of Radiology, University of Missouri, Columbia, MO 65211, USA

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2020 in Radiology
Verified
Journal Article
Closed access
HHHiroto Hatabu
Hiroto Hatabu
YOYoshiharu Ohno
Yoshiharu Ohno
WGWarren B. Gefter
Warren B. Gefter
GPGrace Parraga
Grace Parraga
BMBruno Madore
Bruno Madore
FSFor The Fleischner Society
For The Fleischner Society
Due to technical advances in pulmonary MRI, the Fleischner Society offers its consensus recommendations for the clinical use of MRI in evaluating patients with common lung disorders. Pulmonary MRI provides structural and quantitative functional images of the lungs without ionizing radiation, but it has had limited clinical use due to low signal intensity from the lung parenchym...

1 March 2017 in Journal of Cystic Fibrosis
Verified
Journal Article
Open access
TATalissa A. Altes
Talissa A. Altes
MJMac Johnson
Mac Johnson
MFMeredith Fidler
Meredith Fidler
MBMartyn Botfield
Martyn Botfield
NTNicholas Tustison
Nicholas Tustison
JMJohn P. Mugler
John P. Mugler
This pilot study evaluated the effect of short- and long-term ivacaftor treatment on hyperpolarized 3He-magnetic resonance imaging (MRI)-defined ventilation defects in patients with cystic fibrosis aged ≥12years with a G551D-CFTR mutation. Part A (single-blind) comprised 4weeks of ivacaftor treatment; Part B (open-label) comprised 48weeks of treatment. The primary outcome was change from baseline in total ventilation defect (TVD; total defect volume:total lung volume ratio). Mean change in TVD ranged from -8.2% (p=0.0547) to -12.8% (p=0.0078) in Part A (n=8) and -6.3% (p=0.1953) to -9.0% (p=0.0547) in Part B (n=8) as assessed by human reader and computer algorithm, respectively. TVD responded to ivacaftor therapy. 3He-MRI provides an individual quantification of disease burden that may be able to detect aspects of the disease missed by population-based spirometry metrics. Assessments by human reader and computer algorithm exhibit similar trends, but the latter appears more sensitive. www.clinicaltrials.gov identifier: NCT01161537.

11 August 2011 in Journal of Magnetic Resonance Imaging
Verified
Journal Article
Open access
NTNicholas Tustison
Nicholas Tustison
BABrian B. Avants
Brian B. Avants
LFLucia Flors
Lucia Flors
TATalissa A. Altes
Talissa A. Altes
ELEduard E. de Lange
Eduard E. de Lange
JGJames C. Gee
James C. Gee
Purpose: To develop an automated segmentation method to differentiate the ventilated lung volume on3He magnetic resonance imaging (MRI).Materials and Methods: Computational processing (CP) for each subject consisted of the following three essential steps: 1) inhomogeneity bias correction, 2) whole lung segmentation, and 3) subdivision of the lung segmentation into regions of similar ventilation. Evaluation consisted of two comparative analyses: i) comparison of the number of defects scored by two human readers in 43 subjects, and ii) simultaneous truth and performance level estimation (STAPLE) in 18 subjects in which the ventilation defects were manually segmented by four human readers.Results: There was excellent correlation between the number of ventilation defects tabulated by CP and reader #1 (intraclass correlation coefficient [ICC] = 0.86), CP and reader #2 (ICC = 0.85), and between the two readers (ICC = 0.97). The STAPLE results from the second analysis yielded the following sensitivity/specificity numbers: CP (0.898/0.905), radiologist #1 (0.743/0.897), radiologist #2 (0.501/0.985), radiologist #3 (0.898/0.848), and the first author (0.600/0.984).Conclusion: We developed and evaluated an automated method for quantifying the ventilated lung volume on3He MRI. The findings strongly indicate that our proposed algorithmic processing may be a reliable, automatic method for quantitating ventilation defects. J. Magn. Reson. Imaging 2011;.

11 August 2020 in Radiology
Verified
Journal Article
Closed access
STSina Tafti
Sina Tafti
WGWilliam J. Garrison
William J. Garrison
JMJohn P. Mugler
John P. Mugler
YSY. Michael Shim
Y. Michael Shim
TATalissa A. Altes
Talissa A. Altes
GMG. Wilson Miller
G. Wilson Miller
Emphysema index based on hyperpolarized xenon 129 diffusion MRI is introduced as a robust, nonionizing alternative to CT for quantifying emphysema burden in chronic obstructive pulmonary disease. Background Apparent diffusion coefficient (ADC) maps of inhaled hyperpolarized gases have shown promise in the characterization of emphysema in patients with chronic obstructive pulmonary disease (...

25 March 2017 in Skeletal Radiology
Verified
Journal Article
Open access
PDF file
PBPaul Michael Bunch
Paul Michael Bunch
TATalissa A. Altes
Talissa A. Altes
JMJoan McIlhenny
Joan McIlhenny
JPJames Patrie
James Patrie
CGCree M. Gaskin
Cree M. Gaskin
To assess reader performance and subjective workflow experience when reporting bone age studies with a digital bone age reference as compared to the Greulich and Pyle atlas (G&P). We hypothesized that pediatric radiologists would achieve equivalent results with each method while digital workflow would improve speed, experience, and reporting quality.

12 March 2018 in Journal of Biomechanical Engineering
Verified
Journal Article
Closed access
PDF file
BSBora Sul
Bora Sul
ZOZachary Oppito
Zachary Oppito
SJShehan Jayasekera
Shehan Jayasekera
BVBrian Vanger
Brian Vanger
AZAmy Zeller
Amy Zeller
AWAnders Wallqvist
Anders Wallqvist
Computational models are useful for understanding respiratory physiology. Crucial to such models are the boundary conditions specifying the flow conditions at truncated airway branches (terminal flow rates). However, most studies make assumptions about these values, which are difficult to obtain in vivo. We developed a computational fluid dynamics (CFD) model of airflows for steady expiration to investigate how terminal flows affect airflow patterns in respiratory airways. First, we measured in vitro airflow patterns in a physical airway model, using particle image velocimetry (PIV). The measured and computed airflow patterns agreed well, validating our CFD model. Next, we used the lobar flow fractions from a healthy or chronic obstructive pulmonary disease (COPD) subject as constraints to derive different terminal flow rates (i.e., three healthy and one COPD) and computed the corresponding airflow patterns in the same geometry. To assess airflow sensitivity to the boundary conditions, we used the correlation coefficient of the shape similarity (R) and the root-mean-square of the velocity magnitude difference (Drms) between two velocity contours. Airflow patterns in the central airways were similar across healthy conditions (minimum R, 0.80) despite variations in terminal flow rates but markedly different for COPD (minimum R, 0.26; maximum Drms, ten times that of healthy cases). In contrast, those in the upper airway were similar for all cases. Our findings quantify how variability in terminal and lobar flows contributes to airflow patterns in respiratory airways. They highlight the importance of using lobar flow fractions to examine physiologically relevant airflow characteristics.